Last, all of the study patients were being treated for active cancer; therefore, the respective CRP values could have been confounded by the cancer type and status, anti-cancer therapies, other medications, steroids, infection, and/or other active inflammatory states (such as other non-gastrointestinal adverse events related to ICI) that are unable to be addressed thoroughly in this study. This evidence concerns the gene CRP and cancer.